FDA Approves Guselkumab as First IL-23 Inhibitor with Both SC and IV Induction Options for UC and CD
- 21 September 2025
- 1 month ago
JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis
- 20 September 2025
- 1 month ago
Guselkumab Reduces Disease Progression In Biologic-Naive Patients With Psoriatic Arthritis: Study
- 07 July 2025
- 3 months ago
Recent News
GLP-1 Receptor Agonists Linked to Lower Risk of Ea...
- 03 November, 2025
Ketogenic diet may protect against stress experien...
- 03 November, 2025
STORM-PE Trial: Mechanical Thrombectomy Shows Supe...
- 03 November, 2025
AIIMS INI CET January 2026 admit cards released
- 03 November, 2025
3 pharma students drown in Payyambalam beach in Ke...
- 03 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.



